Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nanchen

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
JAMA|April 1, 2014
Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohortMaryam Kavousi, Maarten J G Leening, David Nanchen, et al.
BMJ Open|January 17, 2025
Association between the intensity of statin therapy and physical activity 1 year after acute coronary syndrome: a multicentre prospective cohort study in SwitzerlandAlex Boudon, Isabella Locatelli, Baris Gencer, et al.
International Journal of Cardiology|April 21, 2019
Inflammation during acute coronary syndromes - Risk of cardiovascular events and bleedingDavid Nanchen, Roland Klingenberg, Baris Gencer, et al.
Preventive Medicine|July 28, 2022
Smoking cessation and depression after acute coronary syndromeKristina Krasieva, Carole Clair, Baris Gencer, et al.
European Journal of Preventive Cardiology|October 25, 2024
Safety of beta-blocker discontinuation after acute coronary syndromes with preserved or mildly reduced left ventricular ejection fraction: a target trial emulation from a real-world cohortNicolas Johner, Mattia Branca, David Carballo, et al.
Atherosclerosis|October 1, 2021
CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patientsThabo Mahendiran, Roland Klingenberg, David Nanchen, et al.
International Journal of Cardiology|November 1, 2019
Control of cardiovascular risk factors and health behaviors in patients post acute coronary syndromes eligible for protein convertase subtilisin/kexin-9 inhibitorsAudrey Butty, Baris Gencer, Konstantinos C Koskinas, et al.
Journal of Interventional Cardiology|March 25, 2020
Optimal Timing of Invasive Coronary Angiography following NSTEMIThabo Mahendiran, David Nanchen, David Meier, et al.
Journal of Cardiovascular Translational Research|November 27, 2019
Prognosis of Patients with Chronic and Hospital-Acquired Anaemia After Acute Coronary SyndromesThabo Mahendiran, David Nanchen, Baris Gencer, et al.
European Journal of Internal Medicine|January 14, 2015
Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromesBaris Gencer, Nicolas Rodondi, Reto Auer, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
JAMA|April 1, 2014
Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohortMaryam Kavousi, Maarten J G Leening, David Nanchen, et al.
BMJ Open|January 17, 2025
Association between the intensity of statin therapy and physical activity 1 year after acute coronary syndrome: a multicentre prospective cohort study in SwitzerlandAlex Boudon, Isabella Locatelli, Baris Gencer, et al.
International Journal of Cardiology|April 21, 2019
Inflammation during acute coronary syndromes - Risk of cardiovascular events and bleedingDavid Nanchen, Roland Klingenberg, Baris Gencer, et al.
Preventive Medicine|July 28, 2022
Smoking cessation and depression after acute coronary syndromeKristina Krasieva, Carole Clair, Baris Gencer, et al.
European Journal of Preventive Cardiology|October 25, 2024
Safety of beta-blocker discontinuation after acute coronary syndromes with preserved or mildly reduced left ventricular ejection fraction: a target trial emulation from a real-world cohortNicolas Johner, Mattia Branca, David Carballo, et al.
Atherosclerosis|October 1, 2021
CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patientsThabo Mahendiran, Roland Klingenberg, David Nanchen, et al.
International Journal of Cardiology|November 1, 2019
Control of cardiovascular risk factors and health behaviors in patients post acute coronary syndromes eligible for protein convertase subtilisin/kexin-9 inhibitorsAudrey Butty, Baris Gencer, Konstantinos C Koskinas, et al.
Journal of Interventional Cardiology|March 25, 2020
Optimal Timing of Invasive Coronary Angiography following NSTEMIThabo Mahendiran, David Nanchen, David Meier, et al.
Journal of Cardiovascular Translational Research|November 27, 2019
Prognosis of Patients with Chronic and Hospital-Acquired Anaemia After Acute Coronary SyndromesThabo Mahendiran, David Nanchen, Baris Gencer, et al.
European Journal of Internal Medicine|January 14, 2015
Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromesBaris Gencer, Nicolas Rodondi, Reto Auer, et al.
Pageof 14